Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Sumatriptan and Naproxen Sodium Tablets safely and effectively. See full prescribing information for Sumatriptan and Naproxen Sodium Tablets. Sumatriptan and Naproxen Sodium Tablets, for oral use Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Sumatriptan and Naproxen Sodium Tablets is indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older. Limitations of Use: Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with Sumatriptan and Naproxen Sodium Tablets, reconsider the diagnosis of migraine before Sumatriptan and Naproxen Sodium Tablets is administered to treat any subsequent attacks. Sumatriptan and Naproxen Sodium Tablets is not indicated for the prevention of migraine attacks. Safety and effectiveness of Sumatriptan and Naproxen Sodium Tablets have not been established for cluster headache.
- generic_name
- sumatriptan succinate and naproxen sodium
- product_names
- sumatriptan succinate and naproxen sodium
- ndc
- 44183-850, 44183-850-09
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en